Cocrystal Pharma, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Cocrystal Pharma, Inc. reported Cash And Cash Equivalents At Carrying Value of $26.35 million for the year ending 2023.

  • Cocrystal Pharma, Inc. showed a decrease of -29.1% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from Cocrystal Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2024.
  • XBRL data for this metric is available from 2009 to 2023 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2009 to 2023), Cocrystal Pharma, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 4,386.3%.
  • Historical annual values: Fiscal year 2023: $26.35 million | Fiscal year 2022: $37.14 million | Fiscal year 2021: $58.71 million | Fiscal year 2020: $33.01 million | Fiscal year 2019: $7.42 million | Fiscal year 2017: $748.0 thousand | Fiscal year 2016: $3.61 million | Fiscal year 2015: $9.28 million | Fiscal year 2014: $3.97 million | Fiscal year 2013: $1.03 million | Fiscal year 2012: $4.72 million | Fiscal year 2011: $35.4 thousand | Fiscal year 2010: $251.5 thousand | Fiscal year 2009: $587.4 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: